Advancing the global public health agenda for NAFLD: a consensus statement
Open accessThe DOI matches its Crossref record; 194 of the 194 references it cites were found in a registry or an index.
Abstract
Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease that affects approximately one-quarter of the global adult population, causing a substantial burden of ill health with wide-ranging social and economic implications. It is a multisystem disease and is considered the hepatic component of metabolic syndrome. Unlike other highly prevalent conditions, NAFLD has received little attention from the global public health community. Health system and public health responses to NAFLD have been weak and fragmented, and, despite its pervasiveness, NAFLD is largely unknown outside hepatology and gastroenterology. There is only a nascent global public health movement addressing NAFLD, and the disease is absent from nearly all national and international strategies and policies for non-communicable diseases, including obesity. In this global Delphi study, a multidisciplinary group of experts developed consensus statements and recommendations, which a larger group of collaborators reviewed over three rounds until consensus was achieved. The resulting consensus statements and recommendations address a broad range of topics — from epidemiology, awareness, care and treatment to public health policies and leadership — that have general relevance for policy-makers, health-care practitioners, civil society groups, research institutions and affected populations. These recommendations should provide a strong foundation for a comprehensive public health response to NAFLD. Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease with a substantial burden worldwide. In this Consensus Statement, a global multidisciplinary group of experts develop consensus statements and recommendations addressing a broad range of topics on NAFLD to raise awareness and spur action.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30925-9 · Cited by 19,358
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Self-citationChalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
Self-citationGlobal Burden of Disease Cancer Collaboration, Fitzmaurice, C., Allen, C., Barber, R. M., Barregard, L., Bhutta, Z. A., Brenner, H., Dicker, D. J., Chimed-Orchir, O., Dandona, R., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.5688 · Cited by 6,215
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Younossi, Z., Anstee, Q. M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., & Bugianesi, E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.109 · Cited by 5,249
Self-citationEASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Eslam, M., Newsome, P. N., Sarin, S. K., Anstee, Q. M., Targher, G., Romero-Gomez, M., Zelber-Sagi, S., Wai-Sun Wong, V., Dufour, J.-F., Schattenberg, J. M., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.039 · Cited by 4,472
Self-citation2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
Jensen, M. D., Ryan, D. H., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Donato, K. A., Hu, F. B., Hubbard, V. S., Jakicic, J. M., Kushner, R. F., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.004 · Cited by 4,058
MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease
Eslam, M., Sanyal, A. J., George, J., Sanyal, A., Neuschwander-Tetri, B., Tiribelli, C., Kleiner, D. E., Brunt, E., Bugianesi, E., Yki-Järvinen, H., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.312 · Cited by 3,286
Self-citationExpanding consensus in portal hypertension
de Franchis, R. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.05.022 · Cited by 3,078
Research works printed but not linked: 2
- Lazarus, J. V. et al. The global non-alcoholic fatty liver disease (NAFLD) preparedness index: are countries ready to tackle the challenge? Int. Liver Congr. 75 (Suppl. 2), 23–26 (2021).
- Grime, M. M. & Wright, G. in Wiley StatsRef: Statistics Reference Online 1–6 (Wiley, 2011).
Cited by
Items 601–700 of 807
Cap CASP, not SCAP, to fight steatohepatitis
Goessling, W. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.09.014 · Cited by 1
Ding, K. R., Lakshmanan, S., Holda, M. K., Kinninger, A., Manubolu, V. S., Joshi, T., Golub, I. S., Mao, S. S., Budoff, M. J., & Roy, S. K. (2023) · Journal of Computer Assisted Tomography · doi:10.1097/rct.0000000000001521 · Cited by 1
Lee, H., Kang, E. Y., Lee, J., Kim, Y., Kang, S., Kim, H., Kim, H. K., Gang, G., Lee, S. G., Cao, L., et al. (2023) · Food Science and Biotechnology · doi:10.1007/s10068-023-01464-1 · Cited by 1
“Fatty liver disease is associated with an increased risk of cardiovascular diseases, type 2 diabetes, and metabolic syndromes (Diehl and Day, 2017; Lazarus et al., 2022a; b).”
The Peptide AWRK6 Alleviates Lipid Accumulation in Hepatocytes by Inhibiting miR-5100 Targeting G6PC
Liu, J., Liu, Y., Wang, Q., Jin, L., & Zhang, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216141 · Cited by 1
“As of now, there are still no approved drugs for the prevention and treatment of NAFLD [2–4].”
BackgroundQuality Evaluation of Metabolic-Associated Fatty Liver Disease Guidelines and Expert Consensus
Chen, M., Chen, Y., Liu, D., Li, K., Hu, R., Chen, J., Jiang, X., & Lin, J.-Q. (2024) · Hormone and Metabolic Research · doi:10.1055/a-2224-1196 · Cited by 1
“…the sixth item of six articles [15–18, 21, 22] was evaluated as “no”, namely “wheth-er views inconsistent with other articles have been reasonably ex-plained”; and the sixth item of three articles [19, 20, 24] was eval-▶ T h i s do c u m en t w a s do w n l oaded f o r pe r s ona l u s e on l y .”
BackgroundHeredia, N. I., John, J. C., Singh, S. K., Hwang, J. P., Strong, L. L., Balakrishnan, M., & McNeill, L. H. (2024) · INQUIRY The Journal of Health Care Organization Provision and Financing · doi:10.1177/00469580241241272 · Cited by 3
Liu, W., Shi, L., Yuan, M., Zhang, Y., Li, Y., Cheng, C., Liu, J., Han, Y., & An, L. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02281-z · Cited by 1
“Alterations in the lipid storage and transport, insulin response, beta-oxidation, and autophagy and an imbalance in nuclear receptor and chemokines signaling are involved in hepatocyte damage, repair and regeneration [9–11].”
BackgroundLazo, M., Li, J., Hirsch, J. A., Moore, K., Auchincloss, A. H., Tabb, L. P., Barrientos‐Gutiérrez, T., Clark, J. M., Solga, S. F., Budoff, M. J., et al. (2024) · Health & Place · doi:10.1016/j.healthplace.2024.103392 · Cited by 1
Self-citationAlkathem, J. A., Almasary, M. H., Almuwalad, N., Alrezqi, W. A., Khamag, Y. A., Alluqmani, Y. A., Alali, A. A., & Almoslem, A. R. (2024) · Journal of Advanced Trends in Medical Research · doi:10.4103/atmr.atmr_78_24 · Cited by 1
The Novel Long-Acting Peptide S6-FA Attenuates Liver Fibrosis In Vitro and In Vivo
Li, M., Qi, L., Huang, J. Y., Li, H., Cheng, W., Shi, Z., Jiang, X., Zhou, Y., & Jiang, W. (2025) · ACS Omega · doi:10.1021/acsomega.4c10956 · Cited by 1
Zhang, R., Weng, G., Wang, J., Lin, Y.-Y., Chen, Q., Ou, Y., & Yu, J. (2025) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002959 · Cited by 1
“Consequently, numerous researchers advocate for the establishment of a robust framework aimed at crafting basic public health interventions to mitigate the burden of NAFLD [4].”
Rashdan, H. R. M., Hassan, S., Maher, S., & Okasha, H. (2025) · Scientific Reports · doi:10.1038/s41598-025-02483-0 · Cited by 1
Wu, Z., Liang, Y., Zeng, L., Fang, J., & He, J. (2025) · Journal of Health Population and Nutrition · doi:10.1186/s41043-025-01015-w · Cited by 1
“Additionally, NAFLD imposes a considerable economic burden on both affected individuals and society [8], with the economic burden of this disease in Europe reaching an astonishing €3.5 billion in 2019 alone [9].”
InfluentialZhong, D., Deng, S., Dong, Y., Qian, Y., Zhu, S., Hu, M., Liu, M., Tan, K., & Tang, H. H. (2025) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000003077 · Cited by 1
Parimi, M., Arefhosseini, S., Tutunchi, H., Arefhosseini, S. R., & Ebrahimi‐Mameghani, M. (2025) · International Journal of Clinical Practice · doi:10.1155/ijcp/8660821 · Cited by 1
“Nonalcoholic fatty liver disease (NAFLD) is a liver disorder described by the accumulation of triglycerides (TGs) more than 5%–10% of the liver weight in the absence of etiologies, such as alcohol abuse, medications, and viral hepatitis [1–5].”
Jiang, Y., Shao, Y., Xue, J., Chen, Z., Liu, Q., Chen, S., Gu, X., Zhang, S., & Tang, L. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.119390 · Cited by 1
Song, H., Dong, X., Niu, Q., Qian, Y., Zhu, X., Zhao, H., Li, C., Lu, G., & Liu, X. (2025) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s546590 · Cited by 1
“2,4 5–8 A recent UK Biobank study has elucidated negative correlations between liver fibrosis and cognitive function, under-scoring the pivotal role of inflammation in the liver-brain axis.”
Albarmawi, H., Dabbous, F., Aly, A., Yousif, A., Huse, S., Jara, M., Quintero, A., & Lawitz, E. (2025) · Current Medical Research and Opinion · doi:10.1080/03007995.2025.2596430 · Cited by 1
Qing, G., Peng, B., & Peng, H. (2026) · Scientific Reports · doi:10.1038/s41598-025-34958-5 · Cited by 1
Dwidar, A. M., Ferra, A. I., Dwidar, A. M., Esmail, E. S., & Elkafoury, R. M. (2026) · Egyptian Liver Journal · doi:10.1186/s43066-025-00488-y · Cited by 1
“Liver fibrosis has a major influence on the prognosis of individuals with MASLD because it can result in cirrhosis, hepatocellular carcinoma (HCC), and liver-related mortality [27, 28].”
A potential therapeutic effect of 84-B10 in MASLD through promotion of FASN degradation
Bai, Y.-P., Yin, Y., Wang, S.-M., Chen, J., Zhang, Z., Zhu, Z.-Q., Shao, G.-X., Zhu, Y., Jiang, Y.-Y., Sun, B.-C., et al. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01745-x · Cited by 1
“MASH can cause liver damage, in fl ammation, and scar formation, leading to cirrhosis and hepatocellular carcinoma [8, 9].”
Chen, Q., Liu, L., Feng, J., Zhang, C., & Zhang, Z. (2026) · Scientific Reports · doi:10.1038/s41598-026-43311-3 · Cited by 2
“MASLD has become a major global health concern, with increasing prevalence and limited effective therapeutic options 28,29 .”
Irregular meal timing and cardiometabolic risk clustering in MASLD: A case-control study
Sguazzini, E., Colucci, G., Martínez, A. M., Alvarado, M. E. P., Vallecillo, M. C., Pereira, W., Gaitan, M., & Lampertico, P. (2026) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2026.102807 · Cited by 1
Ramadhan, D. S., & Mustafa, I. (2026) · BMC Nutrition · doi:10.1186/s40795-026-01309-0 · Cited by 1
“Inadequate screening tools and limited population-based studies have resulted in wide-ranging global estimates of 25% to 30% of adults living with fatty liver disease [1, 2].”
Jiménez-González, C., Vélez, P. A., Cayon, L., García-Garrido, A. B., Garmilla, N. F., Cuadrado, A., Iruzubieta, P., & Crespo, J. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15093259 · Cited by 1
“This perspective aligns with international proposals advocating for the recognition of MASLD as a global public health priority requiring coordinated policy responses [23].”
Self-citationLi, Q., Zhang, X., Zhao, F., Zhang, D., Wang, W. J., Zhang, Z., & Yang, F. (2026) · Nutrition & Metabolism · doi:10.1186/s12986-026-01141-0 · Cited by 1
“Beyond these, MASLD is also associated with a decrease in quality of life and brings a substantial socio-economic burden [7, 8].”
Chowdhary, R., Song, G.-Q., Goyal, M. K., Vuthaluru, A. R., Arora, K., Chowdhary, R., Patel, M., Batta, A., Koo, T.-H., Sunkesula, V., et al. (2026) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v17.i2.118130 · Cited by 1
Xl, M., Song, J., Hong, X., & Lin, Z. (2026) · Metabolites · doi:10.3390/metabo16060378 · Cited by 1
“Metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as the defining chronic liver disorder of the metabolic era, with a rapidly rising global prevalence that shows no sign of geographical containment [1–4].”
Chen, Y., Yang, X., Shen, W., Zhang, P., Yang, X., Xu, X., & Lu, D. (2026) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.70347 · Cited by 1
“4,5 With the growing clinical trials of MASH, many pharmacological agents have shown promising prospects.”
Wu, X., Hou, X., Yin, J., Li, Y., Xiong, C., Liu, H., & Meng, H. (2026) · BMC Gastroenterology · doi:10.1186/s12876-026-04983-3 · Cited by 1
“Liver biopsy, the gold standard for evaluating hepatic fibrosis, is limited in clinical practice by its invasiveness, sampling variability, and poor patient acceptance [4].”
Toshikuni, N. (2026) · Metabolites · doi:10.3390/metabo16080586 · Cited by 1
Gee, M. F. W., Billin, A. N., Chalfin, D. B., Fonstad, R. K., Devol, E. B., Feld, J. J., Patel, K., & Sanyal, A. J. (2026) · JHEP Reports · doi:10.1016/j.jhepr.2026.102041 · Cited by 1
Self-citationA Path Toward Improving Nonalcoholic Fatty Liver Disease Care Among Non-hepatologists
Liangpunsakul, S. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.03.014 · Cited by 1
Ginès, P., Buti, M., Lazarus, J. V., & Sangro, B. (2022) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2022.07.018 · Cited by 1
Self-citationMetabolic associated liver disease
Testino, G., & Pellicano, R. (2022) · Panminerva Medica · doi:10.23736/s0031-0808.22.04730-9 · Cited by 1
Kornilova, E. B., & Hołownia-Voloskova, M. E. (2022) · Health Care of the Russian Federation · doi:10.47470/0044-197x-2022-66-6-473-477 · Cited by 1
Kim, O. Y., Park, J., Lee, J., Sohn, C., Yoon, M. O., & Lee, M. (2023) · Nutrition Research and Practice · doi:10.4162/nrp.2023.17.1.62 · Cited by 1
“Obesity is a public health problem as the main cause of developing non-communicable diseases, such as metabolic syndrome, type 2 diabetes mellitus (T2DM), hypertension, dyslipidemia, and cardiovascular disease (CVD) [1,4,5].”
Background[Progress on the research of liver diseases in 2022].
Dou, X., Xu, X., Nan, Y., Wei, L., Han, T., Mao, Y., Han, Y., Ren, H., Jia, J., & Zhuang, H. (2023) · PubMed Central · doi:10.3760/cma.j.cn501113-20221226-00611 · Cited by 1
Tyzhnenko, T., Misiura, K. V., Кравчун, Н. А., Gorshunska, M., Pochernyaev, A. K., Krasova, N. S., Gladkih, O., Лещенко, Ж., Fedorová, G., Plohotnichenko, O. O., et al. (2023) · PROBLEMS OF ENDOCRINE PATHOLOGY · doi:10.21856/j-pep.2023.2.05 · Cited by 1
Non-Alcoholic Fatty Liver Disease and the Risk of Future Hepatocarcinoma
Scholten, A. (2024) · Science Insights · doi:10.15354/si.24.re1000 · Cited by 1
Das, B., Jain, S., Rao, S. K., Yadav, B., Jameela, S., Rana, R. K., Rao, B. C. S., Rao, M. M., & Srikanth, N. (2024) · Journal of Research in Ayurvedic Sciences · doi:10.4103/jras.jras_106_24 · Cited by 1
Sirchak, Y. S., Корнаш, В. В., Дутко, О. О., Lopit, M. M., Устич, О. В., & Грига, В. И. (2024) · Wiadomości Lekarskie · doi:10.36740/wlek/195168 · Cited by 1
“The incidence of non-alcoholic steatohepatitis (NASH) is projected to increase by 56% over the next 10 years [2-4].”
Pan, L.-X., Tian, W. X., Huang, Z.-H., Li, J., Su, J., Wang, Q., Fan, X., & Zhong, J. (2025) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2025.106751 · Cited by 2
Kock, J., Betancur, J. F., Bolaños-López, J. E., Pérez, L. E., Bello-Gándara, C. J., González-Patiño, F. J., Vanegas, J. S., Manga-Peña, J. D., & Badillo-Blanco, C. A. (2025) · Hepatología · doi:10.59093/27112330.134 · Cited by 1
Non-alcoholic fatty liver disease and chronic kidney disease
Туркина, С. В., Андреевна, Т. И., & Титаренко, М. Н. (2024) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-230-10-49-61 · Cited by 1
Amorim, R., Marques, M. P., Varela, C. L., Días, M. I., Barros, L., Teixeira, J., Oliveira, P. J., & Cabral, C. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.107483 · Cited by 1
Suenghataiphorn, T., Tribuddharat, N., Danpanichkul, P., & Kulthamrongsri, N. (2025) · Asian Biomedicine · doi:10.2478/abm-2025-0030 · Cited by 1
“Understanding the contemporary trends and inter-country variations in the burden of specific GI and liver diseases across SEA nations is paramount for effective public health planning, resource allocation, and the development of targeted interventions [8, 9].”
A polypill for cardiovascular disease prevention with a focus on non-alcohol steatohepatitis
Joseph, P. G., & Yusuf, S. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac029 · Cited by 1
“It is estimated that NAFLD now affects about a quarter of the adult population.(5) It results from systemic metabolic dysregulation in the presence of disorders such as obesity, diabetes, or metabolic syndrome.”
BackgroundCurrent Research in Public Health: A Channel to Explore a New Chapter of Public Health
Wu, Y. (2022) · Current Research in Public Health · doi:10.31586/crph.2022.423 · Cited by 1
Watanabe, Y., Kinoshita, K., Dumrongkulchart, N., Sasaki, T., Shimizu, M., Yamauchi, Y., & Sato, R. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.10.539979 · Cited by 1
“It is estimated that 20% of patients with NAFLD will develop NASH [3].”
BackgroundRising tide of NAFLD in youth: A warning bell and call to action
Xanthakos, S. A. (2023) · Hepatology · doi:10.1097/hep.0000000000000507 · Cited by 1
Self-citationBiswas, S., & Shalimar, S. (2023) · JGH Open · doi:10.1002/jgh3.12996 · Cited by 1
“14 Rich et al .”
Yang, Y., Yang, Y., & Lu, Y. (2025) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2025.1013 · Cited by 1
Paving the way: the road to be taken for proper NAFLD health care
(2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00538-x
CHANGES IN THE DENTAL STATUS OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
Emelyanov, D. V., & Petrushanko, T. O. (2022) · Ukrainian Dental Almanac · doi:10.31718/2409-0255.1.2022.01
Pár, A., & Pár, G. (2022) · Central European Journal of Gastroenterology and Hepatology · doi:10.33570/ceujgh.8.2.76
Ginès, P., Buti, M., Lazarus, J. V., & Sangro, B. (2022) · Medicina Clínica · doi:10.1016/j.medcli.2022.07.010
Self-citationAfnan, B. H., Shaikh, S. S., Rahim, A., Ahmed, W., Soomro, S., Khan, A., Majeed, A. A., Abrar, N., & Ellahi, B. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs22169842 · Cited by 1
Lane, K. E., Moore, E., Davies, I. G., Mazidi, M., & Patwanala, I. (2022) · Proceedings of The Nutrition Society · doi:10.1017/s0029665122002257
Yang, H., Liu, J., Chen, Q., Zhao, L., & Li, J. (2023) · Research Square · doi:10.21203/rs.3.rs-2492341/v1
The associations between cardiometabolic index and non-alcoholic fatty liver diseasePreprint
Xue, F., Zhang, S., He, L., Yang, N., & Chen, Y. (2023) · Research Square · doi:10.21203/rs.3.rs-2608957/v1
Reply: NAFLD/MAFLD: One size does not fit all, certainly not for children!
Henry, L. L., & Younossi, Z. M. (2023) · Hepatology · doi:10.1097/hep.0000000000000397
Self-citationMit Fasten und Bewegung gegen die Lebersteatose
Sulaj, A., & von Rauchhaupt, E. (2023) · Info Diabetologie · doi:10.1007/s15034-023-4488-3
When gluttony strikes: how high‐fat diet impairs hepatic Ca2+ signalling
Merrild, C., & Johansen, V. B. I. (2023) · The Journal of Physiology · doi:10.1113/jp284742
PDIA4: A Novel ER Stress Protein Regulating Hepatic Lipogenesis in Non-Alcoholic Fatty Liver DiseasePreprint
Su, S., Chen, Y.-C., Chien, C., Chiang, C.-F., Lin, F., Kuo, F.-C., Huang, C., Li, P., Liu, J., Lu, C., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3016609/v1
NONALCOHOLIC FATTY LIVER DISEASE AND ALBUMINURIA : A SYSTEMATIC REVIEW
Amelia, D. N. (2023) · Journal of Advance Research in Medical & Health Science · doi:10.53555/nnmhs.v9i7.1771
Esteatohepatitis no-alcohólica: Desarrollo silencioso de una emergencia en salud pública
Pettinelli, P., Fernández‐Verdejo, R., & Aguirre, C. A. (2023) · Revista chilena de nutrición · doi:10.4067/s0717-75182023000300348
Gridnyev, O., & Chereliuk, N. I. (2023) · Modern Gastroenterology · doi:10.30978/mg-2023-4-21
“Such a high global prevalence and expected increase in the incidence of the disease pose a serious risk to public health and economic burden for the state, which requires interdisciplinary approaches to control the further growth of this disease [23].”
Non-invasive Tests of Fibrosis: Does One Size Fit All?
James, M., & Alazawi, W. (2023) · Digestive Diseases and Sciences · doi:10.1007/s10620-023-08094-x
Wu, H., & Wang, W. (2023) · Clinical Medicine Frontiers · doi:10.57237/j.cmf.2023.03.002
Akyol, T. (2023) · Life and Medical Sciences · doi:10.54584/lms.2023.44
Juárez‐Fernández, M. (2023) · Buleria (Universidad de León) · doi:10.18002/10612/17419
García-Morena, D., Fernández-Cantos, M. V., Maathuis, W., & Kuipers, O. P. (2024) · Research Square · doi:10.21203/rs.3.rs-3875369/v1
Zhu, Q., Li, H., Ao, Z., Xu, H., Luo, J., Kaurich, C., Yang, R., Zhu, P., Chen, S., Wang, X., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20390936
Self-citationZhu, Q., Li, H., Ao, Z., Xu, H., Luo, J., Kaurich, C., Yang, R., Zhu, P., Chen, S., Wang, X., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20390933
Self-citationZhu, Q., Li, H., Ao, Z., Xu, H., Luo, J., Kaurich, C., Yang, R., Zhu, P., Chen, S., Wang, X., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20390930
Self-citationProbiotic potential and antimicrobial activity of Bacteroidales strains to fight fatty liver disease
García-Morena, D. (2024) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.961714585 · Cited by 1
Asakura, E., Brain, D., Senanayake, S. J., & Barnett, A. G. (2024) · doi:10.2196/preprints.62883
Bertran, L., Rusu, E. C., Aguilar, C., Auguet, T., & Richart, C. (2024) · Research Square · doi:10.21203/rs.3.rs-4996622/v1
Association of IRS1 gene Pro512Ala polymorphism with nonalcoholic fatty liver disease
Asadi, A., Rostami, M., Shafiee, R., Ardalani, A., Dehghanitafti, A., Golshadi, Z., Kohansal, K., Ghasemi, F., Najafi, M., Mahmoudi, T., et al. (2024) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-4292-2023-0216
“In spite of the fact that NAFLD affects approximately 25% of the adult population in the world, the exact underlying molecular mechanisms of its pathogenesis are poorly established (1).”
BackgroundLi, Y., & Moshage, H. J. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156055
Xuan, Y., Zhang, Q., Chu, J., & Li, T. (2024) · Research Square · doi:10.21203/rs.3.rs-5101985/v1
Hao, X., Zhang, H., He, H., Tao, L., Tian, L., Zhao, W., & Wang, P. (2024) · Postgraduate Medicine · doi:10.1080/00325481.2024.2436344
“The prevalence of NAFLD is estimated to be around 25%, and it continues to rise in tandem with global obesity rates [4].”
Li, F., Chen, J., Xu, Y., Wang, M., Sun, S., & Zhou, S. (2024) · Natural Product Communications · doi:10.1177/1934578x241293660
“1 Beyond its direct health implications, NAFLD signi fi - cantly contributes to the burden on public health infrastructure and economic systems due to its association with various metabolic disorders.”
Lysosomal Disturbances in Metabolic Disorders
Li, M. (2024) · Research Publications (Maastricht University) · doi:10.26481/dis.20241213ml
Xie, K., Chen, M., An, H., Gao, J., Tang, C., & Huang, Z. (2024) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223241303649
“1,3,4,8 Third, the lack of individual-level data prevented stratified analyses by important variables such as age, sex, or histological stage, which are crucial given the demographic disparities in MAFLD incidence 1,2,4 and the varied inflammatory profiles observed in conditions such as MASH.”
Tian, Y., Yang, L., Liao, W., Xia, J., Wang, Y., Shi, Y., Xia, H. M., Pan, D., Wang, S., Yang, C., et al. (2025) · Food Science and Human Wellness · doi:10.26599/fshw.2024.9250459 · Cited by 1
Breaking the silence: MASLD and the scarcity of data on the Roma population
Iruzubieta, P., & Crespo, J. (2025) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(25)00019-6
Self-citationReview of roles of RNA-binding proteins on NAFLD and the related pharmaceutical measures
Li, C., Yang, F., Yuan, Z., & Wei, X. (2025) · Biomolecules and Biomedicine · doi:10.17305/bb.2025.12465 · Cited by 1
“Nonalcoholic fatty liver disease (NAFLD) is one of the most prevalent liver disorders worldwide, affecting over 25% of the adult population and imposing significant social and economic burdens [1].”
Factors impacting individual health and public health outcomes
Mehta, S. D., & Sulb, A. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-821426-8.00102-3
India's continued response to tackling metabolic disorders and non-communicable diseases
Prasad, M., Rewari, B. B., & Sarin, S. K. (2025) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(25)00131-1
Self-citationEvolving Public Attention to Steatotic Liver Disease: A 20‐Year Analysis (2004–2024)
Danpanichkul, P., Thongprayoon, C., Suparan, K., Kim, D., Wanichthanaolan, O., Wattanachayakul, P., Pang, Y., Muthiah, M. D., Kulkarni, A. V., Yang, J. D., et al. (2025) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.17009
“In contrast to other metabolic diseases, SLD has received relatively little attention [34].”
Reflections on the Lancet Commission on Investing in Health's Global Health 2050 report
Lazarus, J. V., Bansal, M. B., Kanwal, F., Lofton, H., & Cusi, K. J. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01091-8
Self-citationSchreiner, A. D., Zhang, J., Bolus, V., Marsden, J. E., Bays, C., Mohamed, A. S., Moran, W. P., Mauldin, P. D., Gebregziabher, M., & Rockey, D. C. (2025) · Journal of General Internal Medicine · doi:10.1007/s11606-025-09659-4
Shah, S. M., Azhar, E., Tanveer, T., & Farooq, D. M. (2025) · Annual Methodological Archive Research Review · doi:10.63075/f40bgd57
Diagnostic Utility of Lipid Indices for Detecting MASLD in Patients with Metabolic Syndrome
Thomson, E. S., & Oommen, A. T. (2025) · Asian Journal of Medicine and Health · doi:10.9734/ajmah/2025/v23i71277
Macronutrients, Microbiota, and Metabolism: Dietary Strategies Against Obesity and Diabetes
(2025) · Obesity and Diabetes Research · doi:10.47275/2692-0964-132
COMPARISON OF VITAMIN E AND URSODEOXYCHOLIC ACID IN NON-ALCOHOLIC STEATOHEPATITIS (NASH)
AMIN, M., AMIN, F., ATHER, A., & AHMAD, S. (2025) · Pakistan Journal of Intensive Care Medicine · doi:10.54112/pjicm.v5i02.128
Real-World Lifestyle Interventions are a Practical Model to Improve Liver Stiffness
Kasia, C., & Rinella, M. E. (2025) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2025.103201
Self-citation
Metadata
- Authors
- Lazarus, J. V., Mark, H. E., Anstee, Q. M., Arab, J. P., Batterham, R. L., Castera, L., Cortez-Pinto, H., Crespo, J., Cusi, K., Dirac, M. A., Francque, S., George, J., Hagström, H., Huang, T. T.-K., Ismail, M. H., Kautz, A., Sarin, S. K., Loomba, R., Miller, V., Newsome, P. N., Ninburg, M., Ocama, P., Ratziu, V., Rinella, M., Romero, D., Romero-Gómez, M., Schattenberg, J. M., Tsochatzis, E. A., Valenti, L., Wong, V. W.-S., Yilmaz, Y., Younossi, Z. M., Zelber-Sagi, S., the NAFLD Consensus Consortium, Åberg, F., Adams, L., Khatry, M. S. A., Naamani, K. A., Murillo, O. A., Allen, A. M., Alnaser, F., Alqahtani, S. A., Alswat, K., Alvaro, D., Andrade, R. J., Arrese, M., Awuku, Y. A., Ayesha, M., Baatarkhuu, O., Bakieva, S., Basu, R., Bataller, R., Bedri, S., Bosi, E., Bourliere, M., Bruha, R., Bugianesi, E., Burra, P., Buti, M., Byrne, C. D., Calleja, J. L., Carrieri, P., Carter, F., Fernandez, M. I. C., Castillo-Lopez, G., Castro-Narro, G. E., Chan, H. L. Y., Chan, W.-K., Chang, Y., Colombo, M., Coppell, K. J., Corey, K., Craxi, A., Cryer, D., Dassanayake, A., Martins, A. D. A. S., de Ledinghen, V., DelPrato, S., Demaio, A., Desalegn, H., Dillon, J., Duseja, A., Dorairaj, P., Ekstedt, M., El Kassas, M., Elsanousi, O. M., Esmat, G., Fan, J.-G., Farpour-Lambert, N., Flisiak, R., Fouad, Y., Fuchs, M., Gani, R. A., Gerber, L., Ghazinyan, H., Gheorghe, L., Goh, G. B.-B., Grønbæk, H., Gulnara, A., Hamid, S., Hebditch, V., Hickman, I. J., Hocking, S. L., Hunyady, B., Idilman, R., Isakov, V. A., Jamal, M. H., Jepsen, P., Iskandar, N. J., Song, M. J., Sudhamshu, K. C., Kakizaki, S., Kalamitsis, G., Kanwal, F., Kao, J.-H., Kaplan, L., Kawaguchi, T., Khader, Y., Kim, S. U., Kodjoh, N., Koek, G., Koike, K., Komas, N. P., Korenjak, M., Kugelmas, M., Labidi, A., Lange, N. F., Lavine, J. E., Lazo, M., Lee, N., Lesmana, C. R. A., Liu, C.-J., Long, M. T., Lopez-Jaramillo, P., Malekzadeh, R., Mahtab, M. A., Marchesini, G., Marinho, R., Vázquez, S. E. M., Mateva, L., Nlombi, C. M., Melin, P., Mikolasevic, I., Milovanovic, T., Musso, C., Nakajima, A., Nava, E., Nersesov, A. V., Nikolova, D., Norris, S., Novak, K., Oben, J., Ong, J. P., Onyekwere, C., Papatheodoridis, G., Paruk, I., Patel, K., Macedo, M. P., Penha-Gonçalves, C., Figueroa, M. P., Hofmann, W. P., Petta, S., de Oliveira, C. P. M. S., Puri, P., Pan, C. Q., Rac, M., Ralston, J., Ramji, A., Razavi, H., Alvares-da-Silva, M. R., Roberts, S., Roden, M., Rose, T., Rouabhia, S., Rovere-Querini, P., Rowe, I. A., Sadirova, S., Salupere, R., Saparbu, T., Sayegh, R., Sebastiani, G., Seki, Y., Selmo, J., Serme, A. K., Shaw, J. E., Shenoy, T., Sheron, N., Shibolet, O., Silva, M., Skrypnyk, I., Socha, P., Soriano, J., Spearman, C. W., Sridharan, K., Suárez, J. J., Sheriff, D. S., Sung, K.-C., Swain, M., Tacke, F., Taheri, S., Tan, S.-S., Tapper, E. B., Yki-Järvinen, H., Thiele, M., Shawa, I. T., Tolmane, I., Torres, E. A., Trauner, M., Treeprasertsuk, S., Turcanu, A., Valantinas, J., Vesterhus, M., Waked, I., Wild, S. H., Willemse, J., Wong, R. J., Xanthakos, S., Young, D. Y., Yu, M.-L., Zheng, K. I., Zeybel, M., & Zheng, M.-H.
- Affiliations
- Barcelona Institute for Global Health (ES)
- European Association for the Study of the Liver (CH)
- NIHR Newcastle Biomedical Research Centre (GB)
- Pontificia Universidad Católica de Chile (CL)
- University College London Hospitals NHS Foundation Trust (GB)
- Marqués de Valdecilla University Hospital (ES)
- Veterans Health Administration (US)
- University of Washington (US)
- University of Antwerp (BE)
- The University of Sydney (AU)
- Karolinska Institutet (SE)
- City University of New York (US)
- King Fahd Hospital of the University (SA)
- Institute of Liver and Biliary Sciences (IN)
- University of California San Diego (US)
- University of California, Berkeley (US)
- University Hospitals Birmingham NHS Foundation Trust (GB)
- Makerere University (UG)
- Université Paris Cité (FR)
- Northwestern University (US)
- The Graduate Center, CUNY (US)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- The Royal Free Hospital (GB)
- University of Milan (IT)
- Chinese University of Hong Kong (HK)
- Marmara University (TR)
- Inova Health System (US)
- University of Helsinki (FI)
- The University of Western Australia (AU)
- Mayo Clinic (US)
- Johns Hopkins University (US)
- King Saud University (SA)
- Sapienza University of Rome (IT)
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (ES)
- University of Health and Allied Sciences (GH)
- University of KwaZulu-Natal (ZA)
- Mongolian National University of Medical Sciences (MN)
- Ministry of Health of the Republic of Uzbekistan (UZ)
- University of Virginia (US)
- University of Pittsburgh (US)
- Ahfad University for Women (SD)
- Vita-Salute San Raffaele University (IT)
- University of Turin (IT)
- University of Padua (IT)
- University of Southampton (GB)
- Inserm (FR)
- University of the West Indies (BS)
- Universidad de Buenos Aires (AR)
- Union Hospital (HK)
- University of Malaya (MY)
- Kangbuk Samsung Hospital (KR)
- IRCCS Ospedale San Raffaele (IT)
- University of Otago (NZ)
- Harvard University (US)
- University of Kelaniya (LK)
- University of Pisa (IT)
- St. Paul's Hospital Millennium Medical College (ET)
- University of Dundee (GB)
- Post Graduate Institute of Medical Education and Research (IN)
- World Heart Federation (CH)
- Linköping University (SE)
- National Ribat University (SD)
- Cairo University hospitals (EG)
- Shanghai Jiao Tong University (CN)
- Medical University of Białystok (PL)
- Minia University (EG)
- Virginia Commonwealth University (US)
- University of Indonesia (ID)
- Carol Davila University of Medicine and Pharmacy (RO)
- Singapore General Hospital (SG)
- Aarhus University Hospital (DK)
- Aga Khan University (PK)
- British Liver Trust (GB)
- Princess Alexandra Hospital (AU)
- Kuwait University (KW)
- Hlabisa Hospital (ZA)
- Catholic University of Korea (KR)
- National Academy of Medical Sciences (NP)
- National Hospital Organization Takasaki General Medical Center (JP)
- Baylor College of Medicine (US)
- National Taiwan University Hospital (TW)
- Kurume University (JP)
- Jordan University of Science and Technology (JO)
- Yonsei University (KR)
- Université d'Abomey-Calavi (BJ)
- Maastricht University Medical Centre (NL)
- The University of Tokyo (JP)
- Institut Pasteur de Bangui (CF)
- Denver Public Library (US)
- Hôpital La Rabta (TN)
- University Hospital of Bern (CH)
- Columbia University (US)
- Drexel University (US)
- Wilton Park (GB)
- Boston University (US)
- University of Tehran (IR)
- Bangladesh Medical University (BD)
- University of Bologna (IT)
- Centro Hospitalar Lisboa Norte (PT)
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (MX)
- University Hospital St. Ivan Rilski (BG)
- University of Kinshasa (CD)
- Favaloro Foundation (AR)
- Yokohama City University (JP)
- Universidad Autónoma de Nuevo León (MX)
- Ss. Cyril and Methodius University in Skopje (MK)
- St. James's Hospital (IE)
- Ljubljana University Medical Centre (SI)
- Guy's Hospital (GB)
- University of the Philippines Manila (PH)
- Lagos State University (NG)
- National and Kapodistrian University of Athens (GR)
- University Health Network (CA)
- Universidade Nova de Lisboa (PT)
- University of Palermo (IT)
- NYU Langone Health (US)
- World Obesity Federation (GB)
- University of British Columbia (CA)
- Center for Disease Analysis (US)
- Alfred Health (AU)
- Düsseldorf University Hospital (DE)
- University of Leeds (GB)
- Tartu University Hospital (EE)
- Kyrgyz State Medical Academy (KG)
- Saint Joseph University (LB)
- McGill University Health Centre (CA)
- Yotsuya Medical Cube (JP)
- Baker Heart and Diabetes Institute (AU)
- King's College London (GB)
- Tel Aviv University (IL)
- Children's Memorial Health Institute (PL)
- Hospital Universitario de La Princesa (ES)
- University of Cape Town (ZA)
- Arabian Gulf University (BH)
- Universidad San Francisco de Quito (EC)
- University of Calgary (CA)
- Charité – Universitätsmedizin Berlin (DE)
- Weill Cornell Medical College in Qatar (QA)
- Hospital Selayang (MY)
- University of Michigan (US)
- University of Southern Denmark (DK)
- University of Malawi (MW)
- Riga East University Hospital (LV)
- University of Puerto Rico, Medical Sciences Campus (PR)
- Medical University of Vienna (AT)
- Chulalongkorn University (TH)
- Nicolae Testemițanu State University of Medicine and Pharmacy (MD)
- Vilnius University Hospital Santariskiu Klinikos (LT)
- Haraldsplass Diakonale Sykehus (NO)
- National Liver Institute (EG)
- University of Edinburgh (GB)
- Stanford Medicine (US)
- Cincinnati Children's Hospital Medical Center (US)
- National University of Singapore (SG)
- Kaohsiung Medical University (TW)
- First Affiliated Hospital of Wenzhou Medical University (CN)
- Koç University (TR)
- Corresponding author
- Lazarus, Jeffrey V.
- ORCID
- Lazarus, Jeffrey V.
- Mark, Henry E.
- Anstee, Quentin M.
- Arab, Juan Pablo
- Batterham, Rachel L.
- Castera, Laurent
- Cortez-Pinto, Helena
- Crespo, Javier
- Cusi, Kenneth
- Dirac, M. Ashworth
- Francque, Sven
- George, Jacob
- Hagström, Hannes
- Huang, Terry T.-K.
- Ismail, Mona H.
- Sarin, Shiv Kumar
- Loomba, Rohit
- Miller, Veronica
- Newsome, Philip N.
- Ninburg, Michael
- Ocama, Ponsiano
- Ratziu, Vlad
- Rinella, Mary
- Romero, Diana
- Romero-Gómez, Manuel
- Schattenberg, Jörn M.
- Tsochatzis, Emmanuel A.
- Valenti, Luca
- Wong, Vincent Wai-Sun
- Yilmaz, Yusuf
- Younossi, Zobair M.
- Åberg, Fredrik
- Adams, Leon
- Naamani, Khalid Al
- Allen, Alina M.
- Alqahtani, Saleh A.
- Alswat, Khalid
- Alvaro, Domenico
- Andrade, Raúl J.
- Arrese, Marco
- Awuku, Yaw Asante
- Baatarkhuu, Oidov
- Bakieva, Shokhista
- Basu, Rita
- Bataller, Ramon
- Bedri, Shahinaz
- Bosi, Emanuele
- Bugianesi, Elisabetta
- Burra, Patrizia
- Byrne, Christopher D.
- Carrieri, Patrizia
- Chan, Henry Lik Yuen
- Chan, Wah-Kheong
- Chang, Yoosoo
- Colombo, Massimo
- Coppell, Kirsten J.
- Corey, Kathleen
- Cryer, Donna
- Dassanayake, Anuradha
- Desalegn, Hailemichael
- Dillon, John
- Duseja, Ajay
- Ekstedt, Mattias
- Elsanousi, Osama M.
- Esmat, Gamal
- Fan, Jian-Gao
- Flisiak, Robert
- Fouad, Yasser
- Fuchs, Michael
- Gani, Rino A.
- Gerber, Lynn
- Gheorghe, Liana
- Goh, George Boon-Bee
- Grønbæk, Henning
- Hamid, Saeed
- Hickman, Ingrid J.
- Hocking, Samantha L.
- Jamal, Mohammad H.
- Jepsen, Peter
- Song, Myeong Jun
- Kakizaki, Satoru
- Kanwal, Fasiha
- Kao, Jia-Horng
- Kaplan, Lee
- Kawaguchi, Takumi
- Khader, Yousef
- Kim, Seung Up
- Kodjoh, Nicolas
- Koek, Ger
- Koike, Kazuhiko
- Komas, Narcisse Patrice
- Korenjak, Marko
- Kugelmas, Marcelo
- Labidi, Asma
- Lange, Naomi F.
- Lavine, Joel E.
- Lazo, Mariana
- Lee, Nancy
- Lesmana, Cosmas Rinaldi A.
- Liu, Chun-Jen
- Long, Michelle T.
- Malekzadeh, Reza
- Mahtab, Mamun Al
- Marchesini, Giulio
- Marinho, Rui
- Vázquez, Sophia E. Martínez
- Nlombi, Charles Mbendi
- Musso, Carla
- Nakajima, Atsushi
- Norris, Suzanne
- Oben, Jude
- Ong, Janus P.
- Onyekwere, Charles
- Papatheodoridis, George
- Paruk, Imran
- Patel, Keyur
- Macedo, M. Paula
- Figueroa, Marlene Pérez
- Hofmann, Wolf Peter
- Petta, Salvatore
- Puri, Puneet
- Pan, Calvin Q.
- Ralston, Johanna
- Ramji, Alnoor
- Razavi, Homie
- Roberts, Stuart
- Roden, Michael
- Rowe, Ian A.
- Sadirova, Shakhlo
- Sebastiani, Giada
- Seki, Yosuke
- Shaw, Jonathan E.
- Sheron, Nick
- Shibolet, Oren
- Silva, Marcelo
- Socha, Piotr
- Soriano, Joan
- Spearman, C. Wendy
- Sridharan, Kannan
- Sheriff, Dhastagir Sultan
- Sung, Ki-Chul
- Swain, Mark
- Tacke, Frank
- Taheri, Shahrad
- Tan, Soek-Siam
- Tapper, Elliot B.
- Thiele, Maja
- Shawa, Isaac Thom
- Tolmane, Ieva
- Torres, Esther A.
- Trauner, Michael
- Treeprasertsuk, Sombat
- Turcanu, Adela
- Valantinas, Jonas
- Vesterhus, Mette
- Waked, Imam
- Wild, Sarah H.
- Wong, Robert J.
- Xanthakos, Stavra
- Yu, Ming-Lung
- Zheng, Kenneth I.
- Zheng, Ming-Hua
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2021-10-27
- Volume
- 19
- Issue
- 1
- Pages
- 60-78
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W3208129759
- Cited by
- 757
- References
- 193
- Citations by year
- 2026: 100 · 2025: 156 · 2024: 163 · 2023: 201 · 2022: 127 · 2021: 9
- FWCI
- 19.36
- Type
- journal article
- Language
- en
- Open access
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Gastroenterology & Hepatology (publishedVersion)
- UWA Profiles and Research Repository (UWA) (publishedVersion, other-oa)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (publishedVersion, other-oa)
- ePrints Soton (University of Southampton) (acceptedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
- RISalud Institutional Health Repository of Andalucía (submittedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-nd)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Dspace Repository (Marmara Üniversitesi) (submittedVersion, other-oa)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Funders
- Falk Foundation
- Amgen
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Gilead Sciences
- Alexion Pharmaceuticals
- Alnylam Pharmaceuticals
- Celgene
- City University of New York
- Medpace
- Regeneron Pharmaceuticals
- European Federation of Pharmaceutical Industries and Associations
- Arrowhead Pharmaceuticals
- Medicines Company
- Galecto
- Intercept Pharmaceuticals
- NGM Biopharmaceuticals
- Coherus Biosciences
- National Institute for Health and Care Research (RP-2015-06-005)
- Rosetrees Trust
- Novo Nordisk
- Astellas Pharma
- Shionogi
- European Association for the Study of the Liver
- Novo Nordisk Fonden (NNF18OC0054612)
- Servier
- Julius Clinical
- Genentech
- Allergan
- Novartis Pharma
- Takeda Pharmaceuticals International
- Sanofi-Aventis Deutschland
- Janssen Pharmaceuticals
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- non-alcoholic fatty liver disease, public health policy, global health agenda, metabolic syndrome, non-communicable diseases, obesity, health system response, Delphi consensus
- MeSH terms
- Humans, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.